Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy
ACS Nano · 11.08.2026 · 20 (31) · 21798-21811
DOI: 10.1021/acsnano.6c04529 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 31.07.2026. Verfasst von Jiayi Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing100191, China. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Lung Neoplasms, Nanoparticles, Immunotherapy. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Pulmonary delivery of lipid nanoparticle (LNP)-based mRNA vaccines offers a promising strategy for localized lung cancer immunotherapy, yet how distinct pulmonary administration routes determine cellular targeting and therapeutic efficacy remains poorly understood. Here, we systematically evaluate intranasal and intratracheal delivery of mRNA-LNP vaccines and reveal a route-dependent immunological mechanism governing lung-targeted tumor vaccination. Although intratracheal administration yields only a 2.6-fold increase in total pulmonary protein expression compared to intranasal delivery, it produces a striking 26.8-fold enhancement in functional mRNA transfection efficiency within alveolar macrophages, the dominant antigen-presenting cell population in the alveolar space. This selective targeting reprograms alveolar macrophages toward an activated antigen-presenting phenotype, promoting efficient antigen presentation, robust CD8+ T-cell responses, and superior prophylactic and therapeutic efficacy in pulmonary tumor models. Notably, local depletion of alveolar macrophages completely abolishes the antitumor protection conferred by intratracheal vaccination, establishing their indispensable role in mediating pulmonary mRNA vaccine efficacy. Together, these findings provide mechanistic insights into lung-targeted mRNA cancer vaccination driven by alveolar macrophage engagement, providing critical insights for the design of next-generation LNP-based nanomedicines for lung cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing100191, China.
- Beijing Key Laboratory of Advanced Pharmaceutical Preparation, School of Pharmaceutical Sciences, Peking University, Beijing100191, China.
- Department of Pediatrics, Peking University People's Hospital, Beijing100044, China.
- Chemical Biology Center, Peking University, Beijing100191, China.
- Ningbo Institute of Marine Medicine, Peking University, Ningbo315832, China.
ORCID-Profile: Yiguang Wang, Binlong Chen
Förderung
- National Natural Science Foundation of China
- Ministry of Education of the People's Republic of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Beijing Municipality
- Beijing Nova Program
- Peking University Medicine plus X Pilot Program-Key Technologies Research and Development Project
Zitieren
APA
Zhou, J., Li, T., Zhang, W., Qiao, P., Zhang, H., Ding, Z., Lu, Y., Yu, J., Ding, J., Chen, H., Ji, D., Wang, Y., & Chen, B. (2026). Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy. ACS Nano, 20(31), 21798-21811. https://doi.org/10.1021/acsnano.6c04529
Vancouver
Zhou J, Li T, Zhang W, Qiao P, Zhang H, Ding Z, et al. Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy. ACS Nano. 2026;20(31):21798-21811. doi:10.1021/acsnano.6c04529
BibTeX
@article{Zhou2026,
author = {Zhou, Jiayi and Li, Tanzhuoyi and Zhang, Weiwei and Qiao, Panshuang and Zhang, Huiyu and Ding, Zihan and Lu, Yilei and Yu, Jiongran and Ding, Jing and Chen, Hang and Ji, Dezhong and Wang, Yiguang and Chen, Binlong},
title = {Intratracheal Delivery of mRNA Lipid Nanoparticles Reprograms Alveolar Macrophages for Pulmonary Cancer Immunotherapy},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {31},
pages = {21798--21811},
doi = {10.1021/acsnano.6c04529}
}
EUVIMED